‘AIRA' an AI Co-Pilot for Health Workers in LMICs launched during the World Health Assembly 2025
'AIRA' is designed to optimize limited healthcare resources in Low- and Middle-Income Countries (LMICs) by supporting AI-enabled digitization of symptoms and patient history collection; clinical protocol adherence and decision support; and aggregated population health insights.
There are 17 million preventable deaths in LMICs and an estimated shortage of 11 million health workers by 20301. At the same time, more than 40% of community health workers' time is spent on manual data collection, and yet countries do not have population-level data to make informed decisions. AIRA aims to solve this urgent need by freeing up precious health worker time to engage more with patients, while digitizing data automatically.
Speaking at the World Health Assembly side-event on AI, Prashant Warier, CEO and Founder of Qure.ai, said, 'With AI, we can make a seismic shift towards health equity in LMICs. AIRA in the hands of every healthcare worker will free up their time for more patient interactions via automated data collection and better clinical protocol adherence. With AI, we can multiply every dollar spent and realize significantly more impact and returns in LMIC health systems. We have demonstrated this in our last 10 years in TB and are motivated to do the same now for primary healthcare.'
Dr. Michel Sidibé, Special Envoy at the African Union, said, 'Health ministries in developing nations need to deliver healthcare to their populations at a fraction of the budget compared to developed countries. We have to be creative to make this happen. Digital health and AI are most certainly catalysts to improve efficiency, access, and quality of care.'
AIRA is an AI co-pilot for healthcare workers in LMICs. It is built on Large Language Models (LLMs) with a deep understanding of Low- and Middle-Income Country health systems and needs. It is designed to reduce administrative workload and free up time for better patient care, while enabling better protocol adherence and population insights.
About Qure.ai
Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 days ago
- Zawya
Omani research team uses AI to detect genetic heart disorders
Muscat: A groundbreaking research initiative has made significant progress in identifying the genetic causes of cardiomyopathy in the Sultanate of Oman. The study, titled 'Implementation of Machine Learning Approach to Predict Pathogenicity of Genetic Variants Associated with Cardiomyopathy,' utilises Whole Exome Sequencing (WES) and advanced Artificial Intelligence (AI) methodologies to investigate the underlying genetic contributors to this complex heart condition. The research was led by Dr. Ahmed Al Amri, Consultant of Molecular Genetics Lab and Head of Training and Professional Staff Development at the National Genetics Centre of the Royal Hospital. Cardiomyopathy, a heterogeneous group of myocardial disorders, remains a significant health burden worldwide. In the Sultanate of Oman, the genetic basis of the disease has been insufficiently characterised, hindering effective diagnosis and intervention. This study aimed to bridge that gap by conducting genetic analysis on a cohort of Omani families affected by cardiomyopathy. Dr. Ahmed Al Amri explained that central to the research is the development of a novel AI-based analysis model called 'CardioVar.' This model is designed to enhance the interpretation of WES data through the integration of more than 50,000 genetic variants and mutations linked to cardiomyopathy, supported by multiple AI algorithms to ensure analytical precision. The research project achieved a diagnostic success rate of over 80%, uncovering both known and previously unreported genetic mutations, some of which involve genes not previously linked to cardiomyopathy. These findings offer valuable insight into the genetic landscape of the disease within the Omani population and present new opportunities for further research to confirm the clinical relevance of novel variants. The AI model significantly improved both the speed and accuracy of genetic analysis, demonstrating its practical value in overcoming the limitations of traditional sequencing approaches. Dr. Al Amri emphasised that this approach not only advances the understanding of the genetic basis of cardiomyopathy in the Sultanate of Oman but also provides a scalable framework for implementing AI in genomic medicine, enhancing diagnostic accuracy and personalised care. The multidisciplinary research team included Dr. Ahmed Al Amri, Dr. Aisha Al Balushi, Nibras Al Mahrami, Dr. Musallam Al Ariami, Dr. Nadia Al Hashimi, Dr. Mohammed Al Rawahi, Dr. Tuqa Al Lawati, Dr. Bushra Al Shamsi, Dr. Fahad Al Hattali, and Ms. Mashael Al Balushi. Together, they have contributed to a practical model that blends clinical knowledge, laboratory science, and artificial intelligence to achieve high-impact results. This research not only advances the scientific understanding of inherited cardiomyopathy in the Sultanate of Oman but also exemplifies how AI can transform genetic diagnostics. It stands as a national model for the integration of precision medicine into routine clinical care, with plans to expand the study to include other hereditary heart conditions and incorporate its findings into everyday healthcare practices. © Muscat Media Group Provided by SyndiGate Media Inc. (
Gulf Business
6 days ago
- Gulf Business
WHX Tech: The next frontier in healthcare innovation
Image credit: WHX Tech/Website In a bold move that underscores the Middle East's growing leadership in digital health, Read- Held under the patronage of the UAE Ministry of Health and Prevention, Dubai Health Authority, Dubai Health, Emirates Health Services and in partnership with HIMSS, the inaugural WHX Tech event brings together healthcare leaders, tech innovators and investors to tackle the biggest challenges and shape the future of healthcare. Redefining the future of healthcare As healthcare systems worldwide contend with aging populations, rising costs, and increasing demand for personalised care, digital technologies are playing a critical role in shaping the future. WHX Tech is designed to respond directly to these challenges, providing a dedicated platform to explore the latest in artificial intelligence, robotics, remote care, and health data interoperability. According to Solenne Singer, Vice President – Healthcare at Informa Markets, the creation of WHX Tech is a strategic response to global demand for innovation hubs that accelerate the adoption of digital health solutions. 'Dubai offers a unique combination of forward-thinking regulation, smart infrastructure, and regional influence. It's the perfect launchpad for this next-generation event,' Singer said. Global gathering for tech trailblazers WHX Tech is expected to attract over 5,000 digital health professionals, over 300 brands, and 200+ speakers, creating a melting pot of ideas and innovations. From healthcare providers and investors to entrepreneurs and government leaders, the event is poised to drive cross-sector collaboration. WHX tech agenda Attendees can explore a dynamic lineup of panels, live demonstrations, and thought-provoking fireside chats that are set to redefine digital healthcare. From pioneering advancements like AI-driven smart hospitals and space-based medicine to delivering digital health solutions to displaced populations, Participants are encouraged to discover what's in store and begin planning their visit. Three stages, one vision The conference programme at WHX Tech is structured around three dynamic stages, each focused on a unique aspect of healthcare transformation: World X – Global Perspectives on Digital Health Innovation Across three immersive days, World X offers a deep dive into how nations around the globe are embracing digital health at scale. Attendees will explore real-world case studies showcasing the implementation of cutting-edge technologies, including artificial intelligence, diagnostics, remote monitoring, and digital therapeutics. The event provides a rare opportunity to understand how innovations such as robotics, virtual care, and data analytics are actively transforming modern healthcare systems, driving efficiency, equity, and improved patient outcomes. Xcelerate – Catalysing the next generation of health tech leaders Xcelerate brings participants into the heart of the investment conversation, offering a front-row seat to how venture capitalists and angel investors identify the next wave of health tech disruptors. Industry leaders share firsthand insights into what fuels their investment decisions—what sparks interest, what raises red flags, and what convinces them to commit. The stage features the Xcelerate startup pitch competition, as emerging companies compete for a $50,000 equity-free cash prize. It's a rare chance to witness the decision-making process behind the rise of tomorrow's healthcare unicorns, and to gain invaluable insider knowledge on market trends, investor priorities, and innovation trajectories. Future X – Showcasing the frontier of healthcare technology At Future X, the boundary between science fiction and clinical reality continues to blur. This showcase is a launchpad for the most visionary technologies reshaping the future of care—from AI and robotics to quantum computing. Through live demonstrations and product unveilings, innovators from around the world present breakthroughs that are already influencing patient care. It's more than a glimpse of what's next; it's a firsthand experience of how transformative technologies are being built and implemented in real-time, redefining the future of global health. Backed by global experts A key differentiator for WHX Tech is its advisory board, comprising world-renowned digital health experts who ensure the programming remains cutting-edge and globally relevant. Confirmed members include: Dr. David Rhew, global chief medical officer & VP of Healthcare, Microsoft Dr. Sam Shah, director of Healthcare Data Management, NEOM Reenita Das, partner and senior VP, Healthcare and Life Sciences, Frost & Sullivan Dr. Myriam Fernandez, Head of Health Innovation, AWS Dr. James Mault, CEO, BioIntelliSense Their collective insights shape a programme rooted in evidence, scalability, and impact. Meet the health experts who will shape the future of healthcare at WHX Tech: Dr. Avi Mehra – Associate Partner, IBM Healthcare & Life Sciences Dr. Justus Wolff – EU Focus Group on AI Implementation Zayna Khayat, Applied Health Futurist Dr. Devi Shetty – Founder & Chairman, Narayana Health Khulood Mohamed Alsayegh – Head of Clinical Standards and Guidelines Section Health Policies and Standard Department, DHA Dr. Mohammad Al Redha – Director, Health Informatics & Smart Health, DHA Mahesh Alpannan – Head of Digital Health, MOH Malaysia Araceli Camacho – Transformation Director, Hospital Clinic Barcelona These speakers, among others, will address emerging digital health trends, health equity, policy evolution, investment strategies, and entrepreneurial resilience. Strategic alignment with national and global priorities WHX Tech aligns with the UAE's National AI Strategy 2031, the World Health Organization's digital health objectives, and broader efforts toward universal health coverage. By convening decision-makers across tech, healthcare, and policy, the event supports regional and international health agendas. Why attend? With a full spectrum of digital health sectors represented, WHX Tech offers unmatched access to trends, partnerships, and market opportunities. Attendees will benefit from: Curated networking via the Connections Programme, which facilitates 1:1 meetings between buyers and solution providers. An exclusive Investors Programme, giving access to high-growth startups and early-stage deal flow. Presentations from over 200 expert speakers and thought leaders. An event unlike any other Unlike traditional health expos, WHX Tech is purpose-built to drive real-world outcomes. It's more than just a showcase; it's a launchpad for solutions and a meeting point for visionaries looking to transform care models, improve patient experiences, and shape the future of digital health. Whether you are a policymaker, technologist, healthcare provider, or investor, WHX Tech 2025 offers a front-row seat to the most transformative health innovations of our time.
Zawya
6 days ago
- Zawya
Saudi foodtech startup secures $39mln funding round for global expansion plans
Riyadh - Calo, the Middle East's largest foodtech startup, has raised $39 million (SAR 146.27 million) in a series B extension round, bringing the total funding to $64 million (SAR 240 million). Led by AlJazira Capital, Oraseya Capital, Nuwa Capital, STV, Khwarizmi Ventures, and Al Faisaliah Group, the transaction follows an initial $25 million tranche secured in December 2024, according to a press release. The oversubscribed round supports Calo's global expansion plans, integration of recent UK acquisitions, and continued investment in AI-powered personalized nutrition. The CEO and Co-Founder of Calo, Ahmed Al Rawi, commented: 'We're living in an interesting time where AI is transforming our lives, and we're excited to be investing in cutting-edge innovation to explore how Calo can use AI to influence the future of how we discover and eat healthy food.' He added: 'Being vertically integrated with the mission of 'Making Healthy Easy' gives us an edge to develop and scale world-class experiences not just regionally, but also globally.' Calo recently acquired UK-based meal subscription brands Fresh Fitness Food and Detox Kitchen, integrating them into its operations and marking the company's entry into the European market. The company, which now operates more than 10 physical locations across the GCC, grew over 50% year-on-year (YoY) in the first half (H1) of 2025. Calo is piloting Calo Black, an AI-powered private chef experience that uses large language models (LLMs) to understand individual customer preferences through natural conversation and craft personalized daily menus. It is worth noting that Calo partnered with premium gym operator Armah Sports Company to expand wellness and retail offerings through co-located outlets, cross-promotions, and product distribution across gym networks. Riyadh-headquartered Calo operates in Saudi Arabia, the UAE, Bahrain, Qatar, and Kuwait, with expansion now underway in the UK.
